Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
16 August 2021
Closing Date:
14 September 2021
Location(s):
BE1 RÉGION DE BRUXELLES-CAPITALE/BRUSSELS HOOFDSTEDELIJK GEWEST (BE Belgium/BELGIQUE-BELGIË)
Description:
Supply of pharmaceutical specialties based on NITISINONE in capsules

See II.2.4

The object of the contract consists in the acquisition of proprietary pharmaceutical products based on NITISINONE (ATC code A16AX04)

Duration: 2 year + 1 year + 1 year

Download full details as .pdf
The Buyer:
UMC Brugmann
CPV Code(s):
33600000 - Pharmaceutical products